Basic research has provided substantial encouragement that tolerance proces
ses may be harnessed to the benefit of organ transplants. The goal of achie
ving mixed chimerism to ensure a robust tolerance, however elegant, may yet
prove to be too complex and, consequently, risky as a procedure to compens
ate for the breadth of genetic differences, and prior immunological experie
nces of donor and host. Tolerance through regulation may prove to be easier
to generate, but insufficiently robust to maintain. In the end the chosen
protocol will be one that is simple, cheap and can guarantee patient compli
ance. Pragmatically, such a protocol need not be one aimed at clear-cut dru
g-free tolerance, but rather one which is trouble free. This could end up a
s a combination of partial tolerance (where tolerance processes have been h
arnessed) induced through a short-term treatment, in conjunction with easil
y tolerated maintenance therapy with select immunosuppressive drugs. Perhap
s to the patient, the holy grail of tolerance is not as important as the co
mplete assurance that the graft will survive and continue to function in al
l circumstances. Copyright (C) 2001 S. Karger AG, Basel.